Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02597972 · ClinicalTrials.gov registry record · NA
Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation of 3&4 Part Proximal Humerus Fractures
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02597972: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02597972 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02597972, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Will patients who suffer complex humerus fractures have better functional outcomes and less implant failure with shoulder replacement (reverse total shoulder arthroplasty, RTSA) compared to shoulder repair (open reduction and internal fixation, ORIF)?
Interventions
- PROCEDURE Fracture repair
- PROCEDURE Fracture repair with joint replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02597972
The ClinicalTrials.gov registry entry for NCT02597972 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fracture repair is the first listed.
NCT02597972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02597972 about?
NCT02597972 is a clinical study titled "Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation of 3&4 Part Proximal Humerus Fractures". Will patients who suffer complex humerus fractures have better functional outcomes and less implant failure with shoulder replacement (reverse total shoulder arthroplasty, RTSA) compared to shoulder repair (open reduction and internal fixation, ORIF)?
What is the current status of trial NCT02597972?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2015-09. Estimated completion is 2018-12-17.
What interventions are being tested in trial NCT02597972?
The interventions under investigation include: Fracture repair (PROCEDURE), Fracture repair with joint replacement (PROCEDURE).
Who is sponsoring clinical trial NCT02597972?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.